crc press - E-Lib FK UWKS

182 Cell-Penetrating Peptides: Processes and Applications
19. Vivès, E., Brodin, P., and Lebleu, B., A truncated HIV-1 Tat protein basic domain
rapidly translocates through the plasma membrane and accumulates in the cell
nucleus, J. Biol. Chem., 272, 16010, 1997.
20. Schwarze, S.R. et al., In vivo protein transduction: delivery of a biologically active
protein into the mouse, Science, 285, 1569, 1999.
21. Schwarze, S.R., Hruska, K.A., and Dowdy, S.F., Protein transduction: unrestricted
delivery into all cells? Trends Cell Biol., 10, 290, 2000.
22. Langer, M. et al., Novel peptide conjugates for tumor-specific chemotherapy, J. Med.
Chem., 44, 1341, 2001.
23. Schmidt, M.C. et al., Translocation of human calcitonin in respiratory nasal epithelium
is associated with self-assembly in lipid membrane, Biochemistry, 37, 16582,
1998.
24. Marin, M. et al., Targeted infection of human cells via major histocompatibility
complex class I molecules by Moloney murine leukemia virus-derived viruses displaying
single-chain antibody fragment-envelope fusion proteins, J. Virol., 70, 2957,
1996.
25. Sharma, S. et al., Noninfectious virus-like particles produced by Moloney murine
leukemia virus-based retrovirus packaging cells deficient in viral envelope become
infectious in the presence of lipofection reagents, Proc. Natl. Acad. Sci. U.S.A., 94,
10803, 1997.
26. Nguyen, D.M. et al., Gene delivery into malignant cells in vivo by a conjugated
adenovirus/DNA complex, Cancer Gene Ther., 4, 183, 1997.
27. Muzyczka, N., Use of adeno-associated virus as a general transduction vector for
mammalian cells, Curr. Top. Microbiol. Immunol., 158, 97, 1992.
28. Legendre, J.Y. and Szoka, F.C., Liposomes for Gene Therapy, Puisieux, F. et al., Eds.,
Editions de la Santé, Paris, 1995, 667.
29. Scherman, D. et al., Application of lipids and plasmid design for gene delivery to
mammalian cell, Curr. Opin. Biotechnol., 9, 480, 1998.
30. Boussif, O. et al., A versatile vector for gene and oligonucleotides transfer into cells
in culture and in vivo: polyethylenimine, Proc. Natl. Acad. Sci. U.S.A., 92, 7297, 1995.
31. Oehlke, J. et al., Cellular uptake of an alpha-helical amphipathic model peptide with
the potential to deliver polar compounds into the cell interior non-endocytically,
Biochim. Biophys. Acta, 1414, 127, 1998.
32. Chaloin, L. et al., Design of carrier peptide — oligonucleotide conjugate with rapid
membrane translocation and nuclear localization properties, Biochim. Biophys. Res.
Commun., 243, 601, 1998.
33. Wyman, T.B. et al., Design, synthesis, and characterization of a cationic peptide that
binds to nucleic acids and permeabilizes bilayers, Biochemistry, 36, 5616, 1997.
34. Niidome, T. et al., Binding of cationic alpha-helical peptides to plasmid DNA and
their gene transfer abilities into cells, J. Biol. Chem., 272, 15307, 1997.
35. Niidome, T. et al., Chain length of cationic α-helical peptide sufficient for gene
delivery into cells, Bioconjug. Chem., 10, 115, 1999.
36. Futaki, S. et al., Arginine-rich peptides. An abundant source of membrane-permeable
peptides having potential as carriers for intracellular protein delivery, J. Biol. Chem.,
276, 5836, 2001.
37. Morris, M.C. et al., Translocating peptides and proteins and their use for gene delivery,
Curr. Opin. Biotech., 11, 461, 2000.
38. Morris, M.C. et al., A new peptide vector for efficient delivery of oligonucleotides
into mammalian cells, Nucleic Acids Res., 25, 2730, 1997.